Health

Sen. Bill Cassidy calls RFK Jr. a failure and urges Trump to replace him

Louisiana Sen. Bill Cassidy urged President Trump to replace Health Secretary Robert F. Kennedy Jr. following failures on measles outbreaks and food policy.

Official portrait of Congressman Bill Cassidy (R-LA)
United States Congress / Wikimedia Commons, Public domain

WASHINGTON — Republican Sen. Bill Cassidy of Louisiana sharply criticized Department of Health and Human Services Secretary Robert F. Kennedy Jr. on Sunday, describing his tenure as a “series of failures” and calling on the president to replace him.

Speaking on CBS’s “Face the Nation with Margaret Brennan,” Cassidy pointed to rising healthcare expenses, the loss of the nation’s measles elimination status, infant deaths from measles, and a lack of progress regarding ultra-processed foods as key reasons the administration needs a change in leadership.

“This has been a failure. If I were president, I would choose someone else because there needs to be accountability for higher health care costs, more measles deaths, losing elimination status, and no progress on processed foods,” Cassidy said during the interview.

Strained Relationship and Unfulfilled Promises

Cassidy, a medical doctor who is set to leave the Senate early next year following a reelection loss, has engaged in a public dispute with the health secretary for months regarding vaccine guidance and broad public health policies. Kennedy’s confirmation as HHS secretary last year relied heavily on support from Cassidy, who ultimately voted to confirm him after receiving what he described as explicit promises of a collaborative working arrangement with the administration.

However, Cassidy indicated on Sunday that the promised partnership failed to materialize. The public feud intensified after Kennedy claimed in remarks on Nov. 9 that congressional Republicans had stalled his agenda. Kennedy asserted that with Republicans losing their Senate majority in the upcoming term, lawmakers would forfeit their influence over his agency.

“The Senate no longer has any leverage over me. And that’s a big deal. I don’t think anything is going to get in our way now,” Kennedy said last week, while highlighting President Donald Trump’s incoming chief of staff, Stephen Miller, as an ally of his movement.

Cassidy rejected Kennedy’s narrative, arguing that the secretary was attempting to deflect responsibility for administrative shortcomings.

“He was supposed to be doing something positive on ultra-processed foods — that’s what MAHA moms wanted. There’s been minimal progress, and now we’ve lost our measles elimination status, and we have infants dying from measles,” Cassidy said. “So if you’re a MAHA mom and you are hoping for something better — and hundreds of them contacted me during this debate about whether to support the secretary for HHS secretary, that’s what they wanted — they have every right to be disappointed.”

Impact on Presidential Legacy and Public Health

Cassidy cautioned that ongoing issues within the department risk damaging the administration’s overall record. He noted that voters signaled dissatisfaction with the healthcare status quo during the midterm elections and urged the president to step in.

The senator argued that higher costs and worsening disease outcomes will “taint the president’s legacy,” adding, “If the president wants actually something positive, he should change.”

When asked about potential impeachment efforts raised by some House Democrats, Cassidy downplayed congressional proceedings, noting that lawmakers “can impeach, I guess, over a ham sandwich,” while reiterating that the primary focus should remain on the president’s decision.

Addressing public health concerns directly, Cassidy highlighted the dangers of low vaccination rates. He noted that unvaccinated adults risk carrying severe illnesses to vulnerable populations, including infants too young for vaccination, pregnant women, and immunocompromised individuals, calling on the White House to consistently emphasize public protection.

Upcoming Senate Vote on FDA Nominee

The dispute comes as the Senate Committee on Health, Education, Labor and Pensions, chaired by Cassidy, prepares to vote this week on Dr. Heidi Overton’s nomination to lead the Food and Drug Administration.

Cassidy stated he remains undecided on whether Overton’s nomination will move out of the committee. He said he has spent the past week consulting with Overton, advisers, and fellow Republican committee members while continuing to evaluate her qualifications.

“I still have questions, and so I cannot tell you the outcome of that vote right now,” Cassidy said.